XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 48,503 10,364,663      
Balance at Dec. 31, 2019 $ 0 $ 10 $ 355,220 $ (348,335) $ 6,895
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares) 0 74,140,297      
Issuance of common stock in public offerings, net of commissions and issuance costs $ 0 $ 74 23,574 0 23,648
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units (in shares) 0 416,119      
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units $ 0 $ 1 27 0 28
Employee stock-based compensation 0 0 1,160 0 1,160
Accretion of Series A preferred stock dividends 0 0 (2,901) 0 (2,901)
Net and comprehensive loss $ 0 $ 0 0 (14,376) (14,376)
Balance (in shares) at Sep. 30, 2020 48,503 84,921,079      
Balance at Sep. 30, 2020 $ 0 $ 85 377,080 (362,711) 14,454
Balance (in shares) at Jun. 30, 2020 48,503 51,339,024      
Balance at Jun. 30, 2020 $ 0 $ 51 365,684 (358,186) 7,549
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares) 0 33,221,725      
Issuance of common stock in public offerings, net of commissions and issuance costs $ 0 $ 33 11,979 0 12,012
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units (in shares) 0 360,330      
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units $ 0 $ 1 0 0 1
Employee stock-based compensation 0 0 384 0 384
Accretion of Series A preferred stock dividends 0 0 (967) 0 (967)
Net and comprehensive loss $ 0 $ 0 0 (4,525) (4,525)
Balance (in shares) at Sep. 30, 2020 48,503 84,921,079      
Balance at Sep. 30, 2020 $ 0 $ 85 377,080 (362,711) 14,454
Balance (in shares) at Dec. 31, 2020 52,369 84,926,129      
Balance at Dec. 31, 2020 $ 0 $ 85 380,332 (367,341) 13,076
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares) 0 10,000,000      
Issuance of common stock in public offerings, net of commissions and issuance costs $ 0 $ 10 13,067 0 13,077
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units (in shares) 0 264,826      
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units $ 0 $ 1 0 0 1
Employee stock-based compensation 0 0 960 0 960
Accretion of Series A preferred stock dividends 0 0 (3,132) 0 (3,132)
Net and comprehensive loss $ 0 $ 0 0 (12,416) (12,416)
Conversion of Series B preferred stock into common stock (in shares) (93) 372,000      
Conversion of Series B preferred stock into common stock $ 0 $ 0 0 0 0
Balance (in shares) at Sep. 30, 2021 52,276 95,562,955      
Balance at Sep. 30, 2021 $ 0 $ 96 391,227 (379,757) 11,566
Balance (in shares) at Jun. 30, 2021 52,276 95,353,002      
Balance at Jun. 30, 2021 $ 0 $ 95 392,032 (374,845) 17,282
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units (in shares) 0 209,953      
Issuance of common stock under officers and directors purchase plan and vesting of restricted stock units $ 0 $ 1 0 0 1
Employee stock-based compensation 0 0 239 0 239
Accretion of Series A preferred stock dividends 0 0 (1,044) 0 (1,044)
Net and comprehensive loss $ 0 $ 0 0 (4,912) (4,912)
Balance (in shares) at Sep. 30, 2021 52,276 95,562,955      
Balance at Sep. 30, 2021 $ 0 $ 96 $ 391,227 $ (379,757) $ 11,566